James P. De Andrade - Concepedia

Author

James P. De Andrade

Also Known As

Carlo Contreras, J Andrade, J P De Andrade, J. Andrade, James De Andrade, James DeAndrade, James P De Andrade, James P. De Andrade

Publications

565

Citations

H-Index

Concepts

All Affiliations

University of Iowa City Of Hope National Medical Center University of Iowa Hospitals and Clinics

About

James P. De Andrade is an author at University of Iowa specializing in medicine, breast cancer, and tumor biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	211
2	Cell Biology	3	3	90
3	Arts	1	1	14
4	Health Sciences	1	1	36
5	Communication	1	1	14

James P. De Andrade

Publications

360

Citations

H-Index

Page 1

	Year	Citations
Inhibiting the SUMO Pathway Represses the Cancer Stem Cell Population in Breast and Colorectal Carcinomas Maria V. Bogachek, Jung M. Park, James P. De Andrade, Stem Cell Reports	2016	70
Sarcopenia is a risk factor for complications and an independent predictor of hospital length of stay in trauma patients James P. De Andrade, Mark Pedersen, Luis J. García, Journal of Surgical Research TraumatologyIndependent PredictorPatient SafetyHospital LengthOutcomes Research	2017	59
Inhibition of RET Increases the Efficacy of Antiestrogen and Is a Novel Treatment Strategy for Luminal Breast Cancer Philip M. Spanheimer, Jung Min Park, Ryan W. Askeland, Clinical Cancer Research	2014	47
EGFR Is Regulated by TFAP2C in Luminal Breast Cancer and Is a Target for Vandetanib James P. De Andrade, Jung M. Park, Vivian W. Gu, Molecular Cancer Therapeutics Breast OncologyOncologyEgfr IsMedicineTumor Growth	2016	36
Receptor Tyrosine Kinase Expression Predicts Response to Sunitinib in Breast Cancer Philip M. Spanheimer, Allison W. Lorenzen, James P. De Andrade, Annals of Surgical Oncology Breast OncologyMedicineReceptor Tyrosine KinaseCancer GrowthBreast Cancer	2015	29
The role of Tcfap2c in tumorigenesis and cancer growth in an activated Neu model of mammary carcinogenesis J M Park, Tong Wu, Anthony R. Cyr, Oncogene Oncogenic AgentMedicineMammary CarcinogenesisBreast CancerTumor Suppressor	2015	25
Performance of ChatGPT on American Board of Surgery In-Training Examination Preparation Questions Catherine G. Tran, Jeremy Chang, Scott K. Sherman, Journal of Surgical Research American BoardPatient SafetySurgical TrainingOutcomes ResearchSurgical Science	2024	20
Targeting the SUMO pathway as a novel treatment for anaplastic thyroid cancer James P. De Andrade, Allison W. Lorenzen, Vincent T. Wu, Oncotarget	2017	18
Natural History of Renal Neuroendocrine Neoplasms: A NET by Any Other Name? Andrew H. Nguyen, Michael P. O’Leary, James P. De Andrade, Frontiers in Endocrinology Surgical OncologyRenal PathologyPathologySurgeryEarlier Stage	2021	17
Unconscious Bias in Speaker Introductions at a Surgical Oncology Meeting: Hierarchy Reigns Over Gender Camille L. Stewart, James P. De Andrade, Narjust Duma, Annals of Surgical Oncology Gendered PerceptionTurn-takingGender IdentityGender StudiesBias	2020	14

Page 1